SULF1 and neoplasm: We unravel the critical roles of SULF1 in suppressing tumor growth of chondrosarcoma by reducing RTK signaling pathway such as cMET which is known to increase malignancy and causes resistance to target therapy (Chu et al., 2020; Du et al., 2016; Li et al., 2019; Sun et al., 2020).